These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 22240353)

  • 21. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke.
    Chan YH; Lau KK; Yiu KH; Li SW; Chan HT; Fong DY; Tam S; Lau CP; Tse HF
    Eur Heart J; 2008 Nov; 29(22):2800-7. PubMed ID: 18812325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
    Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
    Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
    Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
    Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease.
    Shechter M; Shalmon G; Scheinowitz M; Koren-Morag N; Feinberg MS; Harats D; Sela BA; Sharabi Y; Chouraqui P
    Am J Cardiol; 2011 May; 107(9):1255-61. PubMed ID: 21349479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol more effectively than quercetin reduces endothelium degeneration and level of necrosis factor α in patients with coronary artery disease.
    Chekalina NI; Kazakov YM; Mamontova TV; Vesnina LE; Kaidashev IP
    Wiad Lek; 2016; 69(3 pt 2):475-479. PubMed ID: 27717928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of folic acid on endothelial function following acute myocardial infarction.
    Moens AL; Claeys MJ; Wuyts FL; Goovaerts I; Van Hertbruggen E; Wendelen LC; Van Hoof VO; Vrints CJ
    Am J Cardiol; 2007 Feb; 99(4):476-81. PubMed ID: 17293188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery.
    Rakici O; Kiziltepe U; Coskun B; Aslamaci S; Akar F
    Int J Cardiol; 2005 Nov; 105(2):209-15. PubMed ID: 16243115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.
    Caballero AE; Saouaf R; Lim SC; Hamdy O; Abou-Elenin K; O'Connor C; Logerfo FW; Horton ES; Veves A
    Metabolism; 2003 Feb; 52(2):173-80. PubMed ID: 12601628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
    Settergren M; Böhm F; Rydén L; Pernow J
    Eur Heart J; 2008 Jul; 29(14):1753-60. PubMed ID: 18441323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Sclerovit on endothelial dysfunction, hemorheological parameters, platelet aggregation, plasma concentration of homocysteine and progression of atherosclerosis in patients with vascular diseases.
    Horvath B; Szapary L; Debreceni L; Feher G; Kenyeres P; Fulop A; Battyani I; Toth K
    Clin Hemorheol Microcirc; 2009; 42(1):19-28. PubMed ID: 19363237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: a triple-blind, 6-month follow-up, placebo-controlled, randomized trial.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; García-Almagro FJ; Avilés-Plaza F; Parra S; Yáñez-Gascón MJ; Ruiz-Ros JA; García-Conesa MT; Tomás-Barberán FA; Espín JC
    Mol Nutr Food Res; 2012 May; 56(5):810-21. PubMed ID: 22648627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.
    Penumathsa SV; Maulik N
    Can J Physiol Pharmacol; 2009 Apr; 87(4):275-86. PubMed ID: 19370081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisoprolol improved endothelial function and myocardium survival of hypertension with stable angina: a randomized double-blinded trial.
    Lin ZP; Dong M; Liu J
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(6):794-801. PubMed ID: 23609363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol.
    Gal R; Praksch D; Kenyeres P; Rabai M; Toth K; Halmosi R; Habon T
    Cardiovasc Ther; 2020; 2020():7262474. PubMed ID: 32695229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of cardioprotection by resveratrol, a phenolic antioxidant present in red wine (Review).
    Wu JM; Wang ZR; Hsieh TC; Bruder JL; Zou JG; Huang YZ
    Int J Mol Med; 2001 Jul; 8(1):3-17. PubMed ID: 11408943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute resveratrol supplementation in coronary artery disease: towards patient stratification.
    Diaz M; Avila A; Degens H; Coeckelberghs E; Vanhees L; Cornelissen V; Azzawi M
    Scand Cardiovasc J; 2020 Feb; 54(1):14-19. PubMed ID: 31429599
    [No Abstract]   [Full Text] [Related]  

  • 39. Resveratrol more effectively than quercetin reduces endothelium degeneration and level of necrosis factor α in patients with coronary artery disease.
    Chekalina NI; Kazakov YM; Mamontova TV; Vesnina LE; Kaidashev IP
    Wiad Lek; 2016; 69(3 pt 2):475-479. PubMed ID: 28478409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease.
    Tomé-Carneiro J; Gonzálvez M; Larrosa M; Yáñez-Gascón MJ; García-Almagro FJ; Ruiz-Ros JA; Tomás-Barberán FA; García-Conesa MT; Espín JC
    Cardiovasc Drugs Ther; 2013 Feb; 27(1):37-48. PubMed ID: 23224687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.